Obstructive sleep apnea: Influence of hypertension on adiponectin, inflammatory markers and dyslipidemia
- 1 December 2017
- journal article
- Published by Elsevier in Pathophysiology
- Vol. 24 (4) , 305-315
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Impact of Bariatric Surgery on Heme Oxygenase-1, Inflammation, and Insulin Resistance in Morbid Obesity with Obstructive Sleep ApneaObesity Surgery, 2017
- Anthropometric data as predictors of obstructive sleep apnea severityBrazilian Journal of Otorhinolaryngology, 2015
- The Impact of Obstructive Sleep Apnea and Nasal CPAP on Circulating Adiponectin LevelsLung, 2014
- Adiponectin as a routine clinical biomarkerBest Practice & Research Clinical Endocrinology & Metabolism, 2014
- Profile of circulating cytokines: Impact of OSA, obesity and acute cardiovascular eventsCytokine, 2013
- Hypertension and obstructive sleep apneaNature and Science of Sleep, 2013
- Sleep disorders and work performance: findings from the 2008 National Sleep Foundation Sleep in America pollJournal of Sleep Research, 2010
- Obstructive sleep apnoea and its cardiovascular consequencesThe Lancet, 2009
- Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities: Fig. 1—European Respiratory Journal, 2006
- The Occurrence of Sleep-Disordered Breathing among Middle-Aged AdultsNew England Journal of Medicine, 1993